Phase II Trial of Neoadjuvant Cisplatin, 5-Fluorouracil and Interferon-Alpha in Operable Squamous Cell Carcinoma of the Esophagus

Shouki Bazarbashi,Mahmoud Abdelsalam,Tarek Amin,Mazen el-Bassiouni,Hussein Soudy,Amr Elweshi,Hamed Alhusseiny,Khaled Rehman,M. Memon,Dahish Ajarim

Phase II Trial of Neoadjuvant Cisplatin, 5-Fluorouracil and Interferon-Alpha in Operable Squamous Cell Carcinoma of the Esophagus

2008

Shouki Bazarbashi
Mahmoud Abdelsalam
Tarek Amin
Mazen el-Bassiouni
Hussein Soudy
Amr Elweshi
Hamed Alhusseiny
Khaled Rehman
M. Memon
Dahish Ajarim

Background: The combination of 5-fluorouracil (5-FU), cisplatin and interferon (IFN)-α was found to result in a high response rate in advanced esophageal squamous cell carcinoma (SC

Keywords:

Carcinoma
Esophagus
Esophagectomy
Fluorouracil
Biology
Neoadjuvant therapy
Cisplatin
Esophageal cancer
Interferon
Oncology
Internal medicine
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations